Видео ютуба по тегу Azurrx Ceo

James Sapirstein, President and CEO at AzurRx BioPharma
James Sapirstein, President and CEO at AzurRx BioPharma
Thjis Spoor from AzurRx Biopharma on CEO Money
Thjis Spoor from AzurRx Biopharma on CEO Money
AzurRx CEO James Sapirstein discusses the Company's recently licensed niclosamide asset
AzurRx CEO James Sapirstein discusses the Company's recently licensed niclosamide asset
AzurRx Cultivates Therapeutic Proteins for GI Disorder Treatment
AzurRx Cultivates Therapeutic Proteins for GI Disorder Treatment
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about AZRX’s products and therapies.
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about AZRX’s products and therapies.
AzurRx's (AZRX) CEO Thijs Spoor - Investors can expect upcoming news about Phase 2 trial results
AzurRx's (AZRX) CEO Thijs Spoor - Investors can expect upcoming news about Phase 2 trial results
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about their biopharmaceutical products.
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about their biopharmaceutical products.
AzurRX (AZRX) recap of 2016 company highlights
AzurRX (AZRX) recap of 2016 company highlights
AzurRx Biopharma Ceo Discusses Covid Variants, What He Is Excited About, Company Strategy! $AZRX
AzurRx Biopharma Ceo Discusses Covid Variants, What He Is Excited About, Company Strategy! $AZRX
AzurRX Biopharma (NASDAQ: AZRX): Next Generation Targeted GI Therapies
AzurRX Biopharma (NASDAQ: AZRX): Next Generation Targeted GI Therapies
Investor Brand Network (IBN) podcast host Stuart Smith interviews AzurRx CEO, James Sapirstein
Investor Brand Network (IBN) podcast host Stuart Smith interviews AzurRx CEO, James Sapirstein
Thijs Spoor of AzurRx Provides a Company Overview
Thijs Spoor of AzurRx Provides a Company Overview
Best Biopharma Industry Stocks To Invest In Today - AzurRx Biopharma CEO Interview
Best Biopharma Industry Stocks To Invest In Today - AzurRx Biopharma CEO Interview
AzurRx BioPharma, Inc. (NASDAQ: AZRX)
AzurRx BioPharma, Inc. (NASDAQ: AZRX)
AzurRx BioPharma (NASDAQ: AZRX) | James Sapirstein, President & CEO | Innovators with Jane King
AzurRx BioPharma (NASDAQ: AZRX) | James Sapirstein, President & CEO | Innovators with Jane King
AzurRx BioPharma, Inc.’s (NASDAQ:AZRX) interview with James Sapirstein, Chairman & CEO
AzurRx BioPharma, Inc.’s (NASDAQ:AZRX) interview with James Sapirstein, Chairman & CEO
AzurRx BioPharma, Inc. (NASDAQ: AZRX) Webcast | SNN Network
AzurRx BioPharma, Inc. (NASDAQ: AZRX) Webcast | SNN Network
AzurRx BioPharma Describes Phase 2 Clinical Trial for Cystic Fibrosis and Value Catalysts
AzurRx BioPharma Describes Phase 2 Clinical Trial for Cystic Fibrosis and Value Catalysts
Stock2Me Podcast featuring AzurRx Biopharma Inc. President & CEO James Sapirstein
Stock2Me Podcast featuring AzurRx Biopharma Inc. President & CEO James Sapirstein
AzurRx: the latest stock pick for the 16.5% per year high growth Richmond Club Index
AzurRx: the latest stock pick for the 16.5% per year high growth Richmond Club Index